Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up

被引:44
|
作者
Fridell, Mats [1 ]
Backstrom, Martin [1 ]
Hesse, Morten [2 ]
Krantz, Peter [3 ]
Perrin, Sean [1 ]
Nyhlen, Anna [4 ]
机构
[1] Lund Univ, Dept Psychol, SE-22100 Lund, Sweden
[2] Univ Aarhus, Ctr Alcohol & Drug Res, Bartholins Alle, DK-8000 Aarhus C, Denmark
[3] Lund Univ Hosp, Dept Forens Med, SE-22185 Lund, Sweden
[4] Malmo Univ Hosp, Dept Psychiat, SE-20502 Malmo, Sweden
关键词
Cohort study; Premature death; 42-year follow-up; Drug abuse; Psychiatric comorbidity; Personality disorder; Somatic comorbidity; NATIONAL EPIDEMIOLOGIC SURVEY; PERSONALITY-DISORDERS; OVERDOSE MORTALITY; SCID-II; CANNABIS; AMPHETAMINE; PSYCHOSIS; ALCOHOL; PEOPLE; COOCCURRENCE;
D O I
10.1186/s12888-019-2098-3
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundWe need to better understand how the use of different substances and psychiatric comorbidity influence premature death generally and cause-specific death by overdose, intoxication and somatic disorders in people with substance use disorders.MethodA cohort of 1405 patients consecutively admitted to a Swedish detoxification unit for substance use disorders in 1970-1995 was followed-up for 42years. Substances were identified by toxicological analyses. Mortality figures were obtained from a national registry. Causes of death were diagnosed by forensic autopsy in 594 patients deceased by 2012. Predictions were calculated by competing risks analysis.ResultsForty-two per cent of the cohort died during follow-up; more men than women (46.3% vs 30.4%). The standardised mortality ratio (SMR) was calculated as the ratio of observed deaths in males and females in specific age groups in the cohort versus expected deaths in corresponding groups in the general population. SMR was 5.68 for men (CI 95%; 5.04-6.11) and 4.98 (CI 95%; 4.08-5.88) for women. The crude mortality rate (number of deaths divided by number of person observation years) was 2.28% for men and 1.87% for women.Opiates predicted increased risk of premature death while amphetamine and cannabis predicted lower risk. Comorbid psychiatric disorders were identified in 378 cases and personality disorders in 763 cases. Primary psychoses or mood/depression and anxiety disorders predicted a higher risk of premature mortality.Death by overdose was predicted by male gender, younger age at admission to substance treatment, opiate use, and comorbid depression and anxiety syndromes. Cannabis and amphetamine use predicted a lower risk of overdose. Death by intoxication was predicted by male gender, use of sedatives/hypnotics or alcohol/mixed substances, primary psychoses and depression/anxiety syndromes. Premature death by somatic disorder was predicted by male gender and alcohol/mixed abuse.ConclusionPsychiatric comorbid disorders were important risk factors for premature drug-related death. Early identification of these factors may be life-saving in the treatment of patients with substance use disorders.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] The 10-year follow-up of a community-based cohort of people with diabetes: The incidence of foot ulceration and death
    Mohammed, Shijat Ali
    Crawford, Fay
    Cezard, Genevieve Isabelle
    Papathomas, Michail
    ENDOCRINOLOGY DIABETES & METABOLISM, 2024, 7 (01)
  • [42] Myocardial infarction and death findings from a 22-year follow-up of a cohort of 980 employed Swedish men
    Dimberg, L.
    Eriksson, B.
    Hashem, M.
    PUBLIC HEALTH, 2019, 175 : 148 - 155
  • [43] Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study
    Barlati, Stefano
    Nibbio, Gabriele
    Calzavara-Pinton, Irene
    Invernizzi, Elena
    Cadei, Lorenza
    Lisoni, Jacopo
    Valsecchi, Paolo
    Deste, Giacomo
    Vita, Antonio
    SCHIZOPHRENIA RESEARCH, 2022, 250 : 31 - 38
  • [44] Neurocognitive and social cognitive correlates of social exclusion in psychotic disorders: a 20-year follow-up cohort study
    Peralta, Victor
    Sanchez-Torres, Ana M.
    Gil-Berrozpe, Gustavo
    de Jalon, Elena Garcia
    Moreno-Izco, Lucia
    Peralta, David
    Janda, Lucia
    Cuesta, Manuel J.
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2025, 60 (02) : 413 - 426
  • [45] Mortality, cause of death and risk factors in patients with alcohol use disorder alone or poly-substance use disorders: a 19-year prospective cohort study
    Hjemsaeter, Arne Jan
    Bramness, Jorgen G.
    Drake, Robert
    Skeie, Ivar
    Monsbakken, Bent
    Benth, Jurate Saltyte
    Landheim, Anne S.
    BMC PSYCHIATRY, 2019, 19 (1)
  • [46] Mortality, cause of death and risk factors in patients with alcohol use disorder alone or poly-substance use disorders: a 19-year prospective cohort study
    Arne Jan Hjemsæter
    Jørgen G. Bramness
    Robert Drake
    Ivar Skeie
    Bent Monsbakken
    Jūratė Šaltytė Benth
    Anne S. Landheim
    BMC Psychiatry, 19
  • [47] Prediction of recidivism in a long-term follow-up of forensic psychiatric patients: Incremental effects of neuroimaging data
    Delfin, Carl
    Krona, Hedvig
    Andine, Peter
    Ryding, Erik
    Wallinius, Marta
    Hofvander, Bjorn
    PLOS ONE, 2019, 14 (05):
  • [48] Patterns and correlates of alcohol use amongst heroin users: 11-year follow-up of the Australian Treatment Outcome Study cohort
    Darke, Shane
    Slade, Tim
    Ross, Joanne
    Marel, Christina
    Mills, Katherine L.
    Tessson, Maree
    ADDICTIVE BEHAVIORS, 2015, 50 : 78 - 83
  • [49] 5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study
    Martin-Santos, Rocio
    Torrens, Marta
    Poudevida, Sandra
    Langohr, Klaus
    Cuyas, Elisabet
    Pacifici, Roberta
    Farre, Magi
    Pichini, Simona
    de la Torre, Rafael
    ADDICTION BIOLOGY, 2010, 15 (01) : 15 - 22
  • [50] Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study
    Lana, Fernando
    Sanchez-Gil, Carmen
    Adroher, Nuria D.
    Perez, Victor
    Feixas, Guillem
    Marti-Bonany, Josep
    Torrens, Marta
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 1477 - 1487